Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke-Reference-Cited by-同舟云学术

Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke

Published:2012-03-20 Issue:2 Volume:33 Page:364-438
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med. Res. Rev.

Author:

Capra Valérie¹,Bäck Magnus²,Barbieri Silvia S.³,Camera Marina¹³,Tremoli Elena¹³,Rovati G. Enrico¹

Affiliation:

1. Department of Pharmacological Sciences; University of Milan; Via Balzaretti 9 20133 Milan Italy

2. Department of Cardiology and Center for Molecular Medicine; Karolinska University Hospital; Stockholm Sweden

3. Centro Cardiologico Monzino; I.R.C.C.S Milan Italy

Funder

Regione Lombardia

Fondazione Banca del Monte di Lombardia

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/med.21251/fullpdf

Reference690 articles.

1. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes;Coleman;Pharmacol Rev,1994

2. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors;Brink;Pharmacol Rev,2003

3. International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor;Brink;Pharmacol Rev,2004

4. The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo;Chiang;Pharmacol Rev,2006

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction;Scientific Reports;2024-02-09

2. Cross-talk between bioactive lipid mediators and the unfolded protein response in ischemic stroke;Prostaglandins & Other Lipid Mediators;2023-10

3. Preparing to strike: Acute events in signaling by the serpentine receptor for thromboxane A2;Pharmacology & Therapeutics;2023-08

4. Omega-3 to omega-6 fatty acid oxidation ratio as a novel inflammation resolution marker for metabolic complications in obesity;Nutrition, Metabolism and Cardiovascular Diseases;2023-06

5. A year in heart failure: updates of clinical and preclinical findings;ESC Heart Failure;2023-04-18